在糖尿病相关的内皮功能障碍中,miR-210作为治疗点
Aida Collado1, Tong Jiao1, Eftychia Kontidou1
1Division of Cardiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
British journal of pharmacology
|October 14, 2024
概括
微RNA-210 (miR-210) 对糖尿病患者的内皮健康至关重要. 恢复miR-210水平可以通过向PTP1B和GPD2等关键途径来对抗高葡萄糖诱导的内皮功能障碍.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 血管生物学 血管生物学
背景情况:
- 糖尿病与内皮功能障碍有关,这是心血管并发症的前体.
- 微RNAs (miRNAs) 在细胞功能中起着关键作用,但它们在与糖尿病相关的内皮功能障碍中的具体作用尚未完全阐明.
- 微RNA-210 (miR-210) 已成为细胞压力和新陈代谢的潜在调节者.
研究的目的:
- 研究miR-210在内皮细胞中的功能作用.
- 确定miR-210对糖尿病相关的内皮功能障碍的影响.
- 探索调节糖尿病中miR-210水平的治疗潜力.
主要方法:
- 使用db/db和西方饮食诱导的糖尿病小鼠模型,以及miR-210淘汰和转基因小鼠.
- 在高葡萄糖条件下检查了分离的血管和人体内皮细胞.
- 评估内皮依赖放松 (EDR) 和分子标,包括PTP1B,GPD2和氧化应激标志物.
主要成果:
- 在糖尿病小鼠的大动脉中观察到较低的miR-210水平,与EDR受损相关.
- 在糖尿病模型中,miR-210缺乏加剧了内皮功能障碍,而其恢复改善了其.
- 过度表达miR-210减少了PTP1B,GPD2和氧化应激,改善了EDR和氧化的产生.
- 基因和药理上的miR-210上调证明了糖尿病小鼠的治疗疗效.
结论:
- 高葡萄糖对miR-210的下调有助于2型糖尿病的内皮功能障碍.
- miR-210通过抑制PTP1B,GPD2和线粒体氧化应激作用.
- miR-210代表了一种有前途的新型治疗标,用于管理与糖尿病相关的内皮功能障碍.
相关概念视频
Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Type I Diabetes II: Pathophysiology
121
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
Diabetic Retinopathy
65
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
65
Diabetic Nephropathy
49
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
49


